Evidence map›Paper›PMID 40029641›Full record

ArticleJAMA neurology2025

Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage.

Martina B Goeldlin, Simon Fandler-Höfler, Alessandro Pezzini, Anusha Manikantan, Janis Rauch, Stine Munk Hald, Mona Løgtholt Kristensen, Lena Obergottsberger, Jochen A Sembill, David Haupenthal and 30 more

Abstract read
In one paragraph

Article in JAMA neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Hiding in Plain Sight: Inflammation in Iatrogenic Cerebral Amyloid Angiopathy.Neurology(R) neuroimmunology & neuroinflammation · 2025
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Martina B GoeldlinDepartment of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
Simon Fandler-HöflerDepartment of Neurology, Medical University of Graz, Graz, Austria.
Alessandro PezziniDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Anusha ManikantanDepartment of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
Janis RauchDepartment of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
Stine Munk HaldResearch Unit for Neurology, Odense University Hospital and University of Southern Denmark, Odense, Denmark.
Mona Løgtholt KristensenDepartment of Radiology, Odense University Hospital and University of Southern Denmark, Odense, Denmark.
Lena ObergottsbergerDepartment of Neurology, Medical University of Graz, Graz, Austria.
Jochen A SembillDepartment of Neurology, University Hospital Erlangen, Germany.
David HaupenthalDepartment of Neurology, University Hospital Erlangen, Germany.
Kristin Tveitan LarsenDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Nikolaos S AvramiotisDepartment of Clinical Research and Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
Alexandros A PolymerisDepartment of Clinical Research and Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
Charlotte PerioleDepartment of Neurology, Hôpital Pierre-Paul Riquet, CHU Toulouse, Toulouse, France.
Kitti ThiankhawStroke Research Centre, Department of Brain Repair & Rehabilitation, UCL Queen Square Institute of Neurology, London, United Kingdom.
Ida RangusDepartment of Neurology with experimental Neurology, Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Laurent PuyUniversity Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Marco PasiDepartment of Neurology, University Hospital of Tours, Inserm U1253, CIC-IT 1245, Tours, France.
Andrea MorottiASST-Spedali Civili, Brescia, Italy.
Giorgio SilvestrelliStroke Unit, Department of Neuroscience, ASST Mantova, Mantova, Italy.
Giacomo GiacaloneNeurology Unit and Stroke Unit, IRCCS S. Raffaele Hospital, Milano, Italy.
Maurizio PaciaroniDepartment of Neurosciences and Rehabilitation, Azienda Ospedaliero-Universitaria di Ferrara, Italy.
Marialuisa ZeddeNeurology and Stroke Unit, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
Elisa GiorliNeurology Unit, S. Andrea Hospital, La Spezia, Italy.
Rossana TassiStroke Unit, AOU Senese, Siena, Italy.
Marc Delgado-RomeuStroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Urs FischerDepartment of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
Bastian VolbersDepartment of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
Arsany HakimInstitute of Diagnostic and Interventional Neuroradiology, Stroke Research Center Bern, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Werner J Z'GraggenDepartment of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
Christian H NolteDepartment of Neurology with experimental Neurology, Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
David J WerringStroke Research Centre, Department of Brain Repair & Rehabilitation, UCL Queen Square Institute of Neurology, London, United Kingdom.
Nicolas RaposoDepartment of Neurology, Hôpital Pierre-Paul Riquet, CHU Toulouse, Toulouse, France.
Stefan T EngelterDepartment of Clinical Research and Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
Espen S KristoffersenDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Joji KuramatsuDepartment of Neurology, University Hospital Erlangen, Germany.
Thomas GattringerDepartment of Neurology, Medical University of Graz, Graz, Austria.
David GaistResearch Unit for Neurology, Odense University Hospital and University of Southern Denmark, Odense, Denmark.
David J SeiffgeDepartment of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
EURECA collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: : The spatial and temporal distribution of intracerebral hemorrhage (ICH) recurrence are largely unknown. Objective: To assess timing and location of recurrent ICH events in relation to the index ICH event (adjacent ICH [adjICH] vs remote ICH [remICH]). Design, Setting, and Participants: This cohort study was a pooled analysis of individual cohort studies from 2002 to 2021 among hospital-based European cohorts. Patients with 2 or more clinically distinguishable (≥1 recurrent) small vessel disease-related ICH events were included. Data analysis was performed from December 2023 to December 2024. Exposures: ICH location and underlying small vessel disease type. Main Outcomes and Measures: The primary outcome was adjICH, defined by anatomical ICH location and side, and the secondary outcome was time to recurrence. Multivariable regression analyses were conducted adjusting for ICH location, cerebral amyloid angiopathy according to Boston 2.0 or simplified Edinburgh criteria, convexity subarachnoid hemorrhage extension, hypertension, and antihypertensive treatment, including an interaction term for hypertension and antihypertensive treatment. Results: Among 733 patients (median [IQR] age, 72.4 [65.2 to 79.0] years; 346 female [47.2%]), there were 1616 ICH events, including 733 index and 883 recurrent ICH events (range, 1 to 6 recurrences) over a median (IQR) follow-up of 2.53 (0.66 to 4.92) years. There were 340 patients (46.4%) with adjICH and 393 patients (53.6%) with remICH. Among recurrent ICH events, there were 476 adjICH events and 407 remICH events. In multivariable regression analyses, lobar index ICH (adjusted odds ratio [aOR], 2.08; 95% CI, 1.32 to 3.27) and cerebral amyloid angiopathy at index ICH (aOR, 2.21; 95% CI, 1.57 to 3.11) were associated with higher odds of adjICH, while cerebellar index ICH was associated with lower odds of adjICH (aOR, 0.25; 95% CI, 0.07 to 0.89). The median (IQR) time to recurrence was 1.25 (0.36 to 3.38) years for adjICH and 2.21 (0.66 to 4.85) years for remICH. Previous lobar or convexity subarachnoid hemorrhage (coefficient, -0.75; 95% CI, -1.25 to -0.25; P = .003 ), adjICH (coefficient, -0.60; 95% CI, -1.02 to -0.18; P = .005), and the number of previous ICH events (coefficient per 1-event increase, -0.62; 95% CI, -0.93 to -0.32; P < .001) were independently associated with a shorter time to recurrence. Conclusions and relevance: This study found that early recurrence and cerebral amyloid angiopathy were associated with adjICH. These findings suggest that regional, tissue-based factors may facilitate recurrence and that identifying and targeting local vasculopathic changes may represent potential novel treatment targets.

Identifiers

PMID40029641
PMCPMC11877406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.